Phase I/II study of weekly PM00104 (Zalypsis®) in patients with relapsed/refractory multiple myeloma

Br J Haematol. 2016 Feb;172(4):625-8. doi: 10.1111/bjh.13515. Epub 2015 Jun 2.
No abstract available

Keywords: PM00104; dexamethasone; multiple myeloma; phase I/II.

Publication types

  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Drug Resistance
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Maximum Tolerated Dose
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Recurrence
  • Tetrahydroisoquinolines / administration & dosage*

Substances

  • Antineoplastic Agents
  • PM 00104
  • Tetrahydroisoquinolines